Other researchers found that LncRNA-SCRIT can inhibit the transcriptional activity of EZH2 through direct interaction with EZH2 and regulate the proliferation and invasion of breast cancer cells (Pardini and Dragomir, 2021). Here, EZH2 is linked to breast carcinoma.